Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy - PubMed (original) (raw)
. 2009 Aug 15;17(16):5834-56.
doi: 10.1016/j.bmc.2009.07.009. Epub 2009 Jul 10.
Aldo Bianchi, Cristina Battaglia, Laura Belvisi, Martino Bolognesi, Andrea Caprini, Federica Cossu, Elena de Franco, Marilenia de Matteo, Domenico Delia, Carmelo Drago, Amira Khaled, Daniele Lecis, Leonardo Manzoni, Moira Marizzoni, Eloise Mastrangelo, Mario Milani, Ilaria Motto, Elisabetta Moroni, Donatella Potenza, Vincenzo Rizzo, Federica Servida, Elisa Turlizzi, Maurizio Varrone, Francesca Vasile, Carlo Scolastico
Affiliations
- PMID: 19620011
- DOI: 10.1016/j.bmc.2009.07.009
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy
Pierfausto Seneci et al. Bioorg Med Chem. 2009.
Abstract
Novel proapoptotic Smac mimics/IAPs inhibitors have been designed, synthesized and characterized. Computational models and structural studies (crystallography, NMR) have elucidated the SAR of this class of inhibitors, and have permitted further optimization of their properties. In vitro characterization (XIAP BIR3 and linker-BIR2-BIR3 binding, cytotox assays, early ADMET profiling) of the compounds has been performed, identifying one lead for further in vitro and in vivo evaluation.
Similar articles
- Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
Sun H, Stuckey JA, Nikolovska-Coleska Z, Qin D, Meagher JL, Qiu S, Lu J, Yang CY, Saito NG, Wang S. Sun H, et al. J Med Chem. 2008 Nov 27;51(22):7169-80. doi: 10.1021/jm8006849. J Med Chem. 2008. PMID: 18954041 Free PMC article. - Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
Sun H, Nikolovska-Coleska Z, Lu J, Meagher JL, Yang CY, Qiu S, Tomita Y, Ueda Y, Jiang S, Krajewski K, Roller PP, Stuckey JA, Wang S. Sun H, et al. J Am Chem Soc. 2007 Dec 12;129(49):15279-94. doi: 10.1021/ja074725f. Epub 2007 Nov 14. J Am Chem Soc. 2007. PMID: 17999504 Free PMC article. - Structure-activity based study of the Smac-binding pocket within the BIR3 domain of XIAP.
Wist AD, Gu L, Riedl SJ, Shi Y, McLendon GL. Wist AD, et al. Bioorg Med Chem. 2007 Apr 15;15(8):2935-43. doi: 10.1016/j.bmc.2007.02.010. Epub 2007 Feb 11. Bioorg Med Chem. 2007. PMID: 17336535 - Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M, Qadir MI, Perveen N, Ahmad B, Saleem U, Irshad T, Ahmad B. Saleem M, et al. Chem Biol Drug Des. 2013 Sep;82(3):243-51. doi: 10.1111/cbdd.12176. Chem Biol Drug Des. 2013. PMID: 23790005 Review. - Smac mimetics as new cancer therapeutics.
Chen DJ, Huerta S. Chen DJ, et al. Anticancer Drugs. 2009 Sep;20(8):646-58. doi: 10.1097/CAD.0b013e32832ced78. Anticancer Drugs. 2009. PMID: 19550293 Review.
Cited by
- Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.
Lecis D, De Cesare M, Perego P, Conti A, Corna E, Drago C, Seneci P, Walczak H, Colombo MP, Delia D, Sangaletti S. Lecis D, et al. Cell Death Dis. 2013 Nov 14;4(11):e920. doi: 10.1038/cddis.2013.449. Cell Death Dis. 2013. PMID: 24232096 Free PMC article. - Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.
Finlay D, Teriete P, Vamos M, Cosford NDP, Vuori K. Finlay D, et al. F1000Res. 2017 Apr 27;6:587. doi: 10.12688/f1000research.10625.1. eCollection 2017. F1000Res. 2017. PMID: 28529715 Free PMC article. Review. - Proapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Lattuada D, Casnici C, Crotta K, Seneci PF, Corradini C, Truzzi M, Ingegnoli F, Marelli O. Lattuada D, et al. Inflammation. 2015 Feb;38(1):102-9. doi: 10.1007/s10753-014-0012-1. Inflammation. 2015. PMID: 25212046 Free PMC article. - Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
Cossu F, Malvezzi F, Canevari G, Mastrangelo E, Lecis D, Delia D, Seneci P, Scolastico C, Bolognesi M, Milani M. Cossu F, et al. Protein Sci. 2010 Dec;19(12):2418-29. doi: 10.1002/pro.523. Protein Sci. 2010. PMID: 20954235 Free PMC article. - Development of XIAP Antagonists Based On De Novo 8,5-Fused Bicyclic Lactams.
Sheng ZJ, Shi YM, Xu X, Bellynck S, Zhang K, Du ZY, Xu X, Maurel F, Dong CZ. Sheng ZJ, et al. ChemistryOpen. 2019 Jan 15;8(1):34-40. doi: 10.1002/open.201800260. eCollection 2019 Jan. ChemistryOpen. 2019. PMID: 30652062 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous